Moleculin Biotech, Inc. (MBRX) Description, Stock price, News & Info.

#ThinkSabio Latest News

Moleculin Accelerates Planned Unblinded Data Readout for MIRACLE Phase 3 R/R Acute Myeloid Leukemia (AML) Pivotal Trial to H2 2025.